List forks out $125m+ for microbiome Indiana plant

List will increase manufacturing capacity for live biotherapeutics products (LBPs) with its $125+ million investment in Indiana, US.

Millie Nelson, Editor

November 15, 2021

1 Min Read
List forks out $125m+ for microbiome Indiana plant
Image: Stock Photo Secret

List Therapeutics will increase manufacturing capacity for live biotherapeutics products (LBPs) with its $125+ million investment in Indiana, US.

List Therapeutics, whose parent company is South Korean firm Genome & Company, will invest in the city of Fishers, Indiana to build a 110,000 square-foot  outsourcing  facility.

According to the firm, the facility will be commissioned by the end of 2023 and will be located at the Fishers Life Science and Innovation Park. The plant expands List’s offering of end-to-end manufacturing solutions from early-stage development through to clinical trials and commercialization.

ISS_15968_02187-300x261.jpg

Image: Stock Photo Secret

“Our objective with the investment for this new facility is to manufacture LBPs for Phase III clinical trials and for commercial use,” said CEO of List Therapeutics, Jonathan Yongwan Jo.

“With that investment, we aim to become the market leader and premier CMO to bring LBPs to market as we harness bacterial science to help our customers create a healthier world by leveraging List Lab’s 40-plus years of experience and expertise in the industry.”

LBPs  contain live organisms such as bacteria. Unlike probiotics, live biotherapeutics are drugs, developed to the same efficacy and safety standards within the same regulatory framework as any other.

LBPs can target a range of diseases, which includes dermatologic, gut, neurologic, immunologic, reproductive, and oncologic disorders.

List anticipates hiring 210 employees in the Fisher area of biologics manufacturing and quality and regulatory compliance once the plant has been commissioned.

About the Author

Millie Nelson

Editor, BioProcess Insider

Journalist covering global biopharmaceutical manufacturing and processing news and host of the Voices of Biotech podcast.

I am currently living and working in London but I grew up in Lincolnshire (UK) and studied in Newcastle (UK).

Got a story? Feel free to email me at [email protected]

You May Also Like